Courtesy of MMS Holdings

MMS Holdings Inc., a contract research organization (CRO) based in Canton, has announced the appointment of Kelly J. Hill as chief strategy officer.

This appointment will help accelerate the company’s growth as it continues to provide data-driven clinical research services.

“Kelly’s new appointment as Chief Strategy Officer and our recent partnership with Lindsay Goldberg position us to continue helping our clients develop life-changing treatments and bring them to patients,” said Uma Sharma, CEO of MMS Holdings. “Kelly has been my strategic right-hand man at MMS, and as we grow, I look forward to her insight and continued leadership in the years ahead.”

A long-time member of MMS’s executive leadership team, Hill has more than 20 years of business leadership experience and has helped grow the company from its inception to a global company with more than 900 colleagues.

In his new role, Hill will drive the overall corporate strategy, driving long-term sustainable success and ensuring the company’s goals are met. In addition, she will champion the company’s partnerships and alliances.

“I’m grateful for the opportunity to oversee our strategy at such an exciting time for our company,” says Hill. “Building on a strong foundation of great people, processes and exceptional customer service, we will continue to expand our award-winning services in support of high-impact clinical research and successful therapy approvals, which is critical to every member of our global team.”